Farmak JSC, the leader of Ukrainian pharmaceutical industry, launched a promo website for Avouge® Biogel line, a new generation of safe products for contour plastic surgery.
The website offers reference information about Avouge® Biogel line: the cosmetic product description and indications for use.
In addition, the website shows news about Avouge® and allows getting an expert advice on specific features of the product and its use.
Nadiya Derkach, Marketing Consultant, Farmak JSC, says, “Our promo website for Avouge® Biogel line provides a tool to communicate with patients and experts, which will make it possible to communicate the information related to use and effect of Avouge® and Avouge® Plus as promptly and completely as possible. The website will also become a venue for our interactive communications with the target audience”.
Avouge® is a line of fillers for contour plastic surgery, which contain hyaluronic acid (sodium salt form) in 22 mg/ml concentration.
Hyaluronic acid forming part of Avouge® Biogels is obtained by biofermentation from Streptococcus culture using unique patented HESH-process that results in biogel with hybrid properties: elasticity of biphasic and plasticity of monophasic products.
Avouge® contains hyaluronic acid in two conditions: firstly, stabilized with butanediol diglycidyl ether and, secondly, as a linear hyaluronic acid.
The unique structure of hyaluronic acid Avouge® Biogel makes it possible to prolong the effect and achieve the desirable outcome with a smaller volume.
Crosslinking of hyaluronic acid with butanediol diglycidyl ether (BDDE), which forms part of Avouge® Biogel, facilitates prolongation of its effect.
According to the decision of economic courts of all instances (2009-2010), the name “Corvalol” (“Corvalolum”) was used exclusively by one manufacturer as the name of the medicinal product. Information that Corvalol was manufactured by 70 pharmaceutical enterprises of the USSR is not true. In the middle of 20th century, Lomonosov Kyiv Chemical and Pharmaceuti...
On October 30 the next court hearing was held in the case regarding the well-known trademark Corvalol Corvalolum. During the court hearing, after having heard the parties’ arguments and a complete and unbiased analysis of the case-file, the Economic Court ruled to dismiss the claim of Pharmaceutical Firm “Darnitsa” against the Ministry of Economic Deve...
Farmak was granted 7 awards in the contest “Best Corporate Media of Ukraine 2019” held by the Association of Corporate Media of Ukraine. The jury consisted of professionals granted the Grand Prix as the highest award to the corporate newspaper “Farmak Life” and the Company’s website. They were awarded with the title “Best Corpmedia Ukraine […]